247 related articles for article (PubMed ID: 32827337)
1. Chemoradiation-Related Lymphopenia and Its Association with Survival in Patients with Squamous Cell Carcinoma of the Anal Canal.
Lee G; Kim DW; Muralidhar V; Mitra D; Horick NK; Eyler CE; Hong TS; Drapek LC; Allen JN; Blaszkowsky LS; Giantonio B; Parikh AR; Ryan DP; Clark JW; Wo JY
Oncologist; 2020 Dec; 25(12):1015-1022. PubMed ID: 32827337
[TBL] [Abstract][Full Text] [Related]
2. Lymphopenia During Definitive Chemoradiotherapy in Esophageal Squamous Cell Carcinoma: Association with Dosimetric Parameters and Patient Outcomes.
Xu H; Lin M; Hu Y; Zhang L; Li Q; Zhu J; Wang S; Xi M
Oncologist; 2021 Mar; 26(3):e425-e434. PubMed ID: 32960471
[TBL] [Abstract][Full Text] [Related]
3. Cure Rates According to Dose-Intensity of Chemoradiation in T2N0 Squamous Cell Carcinoma of the Anal Canal.
Lustosa IKF; Camandaroba MPG; Mattos BRS; Silva SF; Iseas S; Riechelmann RP
Clin Colorectal Cancer; 2022 Sep; 21(3):e226-e231. PubMed ID: 35753955
[TBL] [Abstract][Full Text] [Related]
4. Lymphocyte Nadir and Esophageal Cancer Survival Outcomes After Chemoradiation Therapy.
Davuluri R; Jiang W; Fang P; Xu C; Komaki R; Gomez DR; Welsh J; Cox JD; Crane CH; Hsu CC; Lin SH
Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):128-135. PubMed ID: 28816138
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of neutrophilia and lymphopenia on survival in anal cancer treated with definitive concurrent chemoradiotherapy: a retrospective multicenter study.
Kim E; Kim TH; Jung W; Kim K; Chang AR; Park HJ; Koh HK; Hong S; Kim KH; Chang JS; Koom WS; Jang WI; Kim MS
Int J Clin Oncol; 2022 Mar; 27(3):553-562. PubMed ID: 34842994
[TBL] [Abstract][Full Text] [Related]
6. The relationship of lymphocyte recovery and prognosis of esophageal cancer patients with severe radiation-induced lymphopenia after chemoradiation therapy.
Deng W; Xu C; Liu A; van Rossum PSN; Deng W; Liao Z; Koong AC; Mohan R; Lin SH
Radiother Oncol; 2019 Apr; 133():9-15. PubMed ID: 30935587
[TBL] [Abstract][Full Text] [Related]
7. Definitive chemoradiotherapy for anal canal cancer: single-center experience.
Tachibana I; Nishimura Y; Inada M; Fukuda K; Ishikawa K; Nishikawa T; Yokokawa M; Nakamatsu K; Kanamori S; Hida JI
Int J Clin Oncol; 2018 Dec; 23(6):1121-1126. PubMed ID: 29992389
[TBL] [Abstract][Full Text] [Related]
8. Definitive chemoradiation in nonmetastatic squamous cell carcinoma anal canal: A single-institution experience.
Kumar V; Bansal S; Badola A; Nautiyal V; Gupta M; Ahmad M; Saini S
J Cancer Res Ther; 2022 Dec; 18(Supplement):S405-S409. PubMed ID: 36510995
[TBL] [Abstract][Full Text] [Related]
9. Role of pelvic chemoradiation therapy in patients with initially metastatic anal canal cancer: A National Cancer Database review.
Abdelazim YA; Rushing CN; Palta M; Willett CG; Czito BG
Cancer; 2019 Jun; 125(12):2115-2122. PubMed ID: 30825391
[TBL] [Abstract][Full Text] [Related]
10. Survival benefits and predictors of use of chemoradiation compared with radiation alone for early stage (T1-T2N0) anal squamous cell carcinoma.
Youssef I; Osborn V; Lee A; Katsoulakis E; Kavi A; Choi K; Safdieh J; Schreiber D
J Gastrointest Oncol; 2019 Aug; 10(4):616-622. PubMed ID: 31392041
[TBL] [Abstract][Full Text] [Related]
11. Patterns of Care and Comparison of Outcomes Between Primary Anal Squamous Cell Carcinoma and Anal Adenocarcinoma.
Malakhov N; Kavi AM; Lee A; Adedoyin P; Sheth N; Lederman AJ; Schreiber D
Dis Colon Rectum; 2019 Dec; 62(12):1448-1457. PubMed ID: 31725581
[TBL] [Abstract][Full Text] [Related]
12. Association between treatment-related lymphopenia and overall survival in elderly patients with newly diagnosed glioblastoma.
Mendez JS; Govindan A; Leong J; Gao F; Huang J; Campian JL
J Neurooncol; 2016 Apr; 127(2):329-35. PubMed ID: 26725885
[TBL] [Abstract][Full Text] [Related]
13. Definitive Pelvic Radiotherapy and Survival of Patients With Newly Diagnosed Metastatic Anal Cancer.
Wang Y; Yu X; Zhao N; Wang J; Lin C; Izaguirre EW; Farmer M; Tian G; Somer B; Dubal N; Schwartz DL; Ballo MT; VanderWalde NA
J Natl Compr Canc Netw; 2019 Jan; 17(1):29-37. PubMed ID: 30659127
[No Abstract] [Full Text] [Related]
14. Salvage Abdominoperineal Resection for Squamous Cell Anal Cancer: A 30-Year Single-Institution Experience.
Hagemans JAW; Blinde SE; Nuyttens JJ; Morshuis WG; Mureau MAM; Rothbarth J; Verhoef C; Burger JWA
Ann Surg Oncol; 2018 Jul; 25(7):1970-1979. PubMed ID: 29691737
[TBL] [Abstract][Full Text] [Related]
15. Surgery Is an Effective Option after Failure of Chemoradiation in Cancers of the Anal Canal and Anal Margin.
Delhorme JB; Severac F; Waissi W; Romain B; Antoni D; Freel KC; Schumacher C; Rohr S; Brigand C; Noël G
Oncology; 2017; 93(3):183-190. PubMed ID: 28571009
[TBL] [Abstract][Full Text] [Related]
16. Chemoradiation vs. local excision in the management of early squamous cell carcinoma of the anus: a systematic review.
Portale G; Parotto M; Pozza A; Scarpa M; Cavallin F
Int J Colorectal Dis; 2022 Sep; 37(9):1937-1944. PubMed ID: 36002749
[TBL] [Abstract][Full Text] [Related]
17. Impact of overall corticosteroid exposure during chemoradiotherapy on lymphopenia and survival of glioblastoma patients.
Hui CY; Rudra S; Ma S; Campian JL; Huang J
J Neurooncol; 2019 May; 143(1):129-136. PubMed ID: 30864102
[TBL] [Abstract][Full Text] [Related]
18. Association Between Lymphopenia and Survival Outcomes in Esophageal Carcinoma Patients Receiving Combined Immunotherapy and Chemoradiotherapy.
Cheng X; Chen B; Wang S; Zhang J; Zhu J; Liu M; Liu S; Xi M
Oncologist; 2023 Aug; 28(8):e606-e616. PubMed ID: 37061835
[TBL] [Abstract][Full Text] [Related]
19. The Role of Multiagent Chemoradiation in the Management and Prognosis of Anal Squamous Cell Carcinoma.
Goffredo P; Utria AF; Hrabe JE; Gribovskaja-Rupp I; Kapadia MR; Hassan I
J Gastrointest Surg; 2019 Apr; 23(4):712-719. PubMed ID: 30644029
[TBL] [Abstract][Full Text] [Related]
20. Primary surgery with or without postoperative radiotherapy in early stage squamous cell carcinoma in the anal canal and anal margin.
Leon O; Hagberg O; Johnsson A
Acta Oncol; 2018 Sep; 57(9):1209-1215. PubMed ID: 29490558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]